IMO last announcement was very positive - with potential drug use for COVID-19 in ARDS management.
I topped up at the bottom 27c. I expect a rebound as the company and its portfolio have value.
Can anyone blame sellers for capitalising their return and selling to make a profit.
I often sell at the top, and reinvest at the bottom if the stock and company has good management, and is over or under valued.
Enjoy your trading fellow posters.
Merc Out
Chartwatch - DXB, page-351
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
0.040(9.09%) |
Mkt cap ! $255.8M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 48.0¢ | 44.0¢ | $1.062M | 2.283M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 47984 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 35315 | 2 |
View Market Depth
| Last trade - 12.10pm 10/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |